Cigna Group Stock Price, News & Analysis

Cigna Corporation (NYSE: CI) reported robust first quarter 2022 results with total revenues of $44.0 billion and adjusted revenues of $44.1 billion, reflecting growth across its businesses. Shareholders earned $1.2 billion or $3.68 per share, up from $3.30 last year. Adjusted income from operations rose to $1.9 billion, or $6.01 per share. The total customer base grew by 3% year-to-date to 190.4 million, while Cigna's 2022 outlook projects at least $177 billion in adjusted revenues. The company continues to invest in innovation and partnerships.

Cigna Corporation (NYSE: CI) has launched a new provider consult service to enhance health outcomes for patients with complex cancers. This service leverages Cigna's Evernorth health services to connect patients and community oncologists with experts from National Cancer Institute designated centers. In pilot results, 40% of patients received beneficial treatment recommendations based on updated research. The initiative aims to improve patient care, showcasing Cigna's integrated oncology solutions that support patients throughout their cancer journey.

Cigna Corporation (NYSE: CI) declared a cash dividend of $1.12 per share of common stock, scheduled for payment on June 23, 2022. Shareholders of record will be confirmed as of the close of business on June 8, 2022. This move reflects Cigna's commitment to returning value to its shareholders, maintaining strong financial health and operational stability.

Cigna Corporation (NYSE:CI) announced that CFO Brian Evanko will present at the BofA Securities 2022 Healthcare Conference on May 11, 2022, at approximately 1:40 p.m. ET in Las Vegas. A live webcast of the presentation will be available on Cigna's investor relations website. Cigna, a global health services company, aims to enhance health and well-being through comprehensive healthcare solutions and maintains a strong international presence with over 185 million customer relationships across more than 30 countries.

Evernorth, a health services subsidiary of Cigna, and Kaiser Permanente announce a five-year collaboration aimed at enhancing access to affordable, high-quality healthcare for Kaiser members. Effective immediately, the partnership allows Kaiser members traveling outside service areas to utilize Cigna's extensive PPO provider network, improving access to urgent and emergency care. Moreover, Evernorth's Accredo specialty pharmacy will become Kaiser’s preferred external pharmacy, promising savings and enhanced services for specialty drug needs.

The Cigna Corporation (NYSE: CI) will announce its first quarter 2022 financial results on May 6, 2022, at 6:30 a.m. ET. A conference call will follow at 8:30 a.m. ET to discuss these results, with call-in numbers provided for domestic and international participants. A replay of the call will be available starting at 12:30 p.m. ET the same day until 11:59 p.m. ET on May 20, 2022. The financial details will also be accessible via the Investor Relations section of Cigna's website.

Cigna Corporation (NYSE:CI) will host its Investor Day on June 3, 2022, in New York City. The event will run from 8:30 a.m. ET to 1:30 p.m. ET, featuring in-depth presentations on corporate strategy and financial targets. A live webcast will be available on Cigna's Investor Relations website, with a replay accessible for four weeks post-event. Cigna is dedicated to enhancing the health and well-being of individuals through integrated health services.

Cigna Corporation (NYSE: CI) announced a strategic plan for capital deployment aimed at enhancing shareholder value, projecting over $12 billion in deployable capital for 2022. This includes $5.4 billion from the sale of its international insurance businesses. The Board approved a $6 billion increase in share repurchase authorization, bringing the total to $10 billion. Cigna plans to allocate more than $7 billion for share repurchases this year, reinforcing confidence in its growth prospects while also approving $450 million for Cigna Ventures to support innovation.